A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company developing next-generation cardiovascular therapeutics, and its clinical development division Sardocor, today announced that the U.S.
ESCMID is the premier annual congress of the European Society of Clinical Microbiology and Infectious Diseases. It takes place from April 17 - 21, 2026 in Munich, Germany.
After a few months away from the spotlight, the royal who suffers from lung disease pulmonary fibrosis made a public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results